Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Free Cash Flow (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Free Cash Flow for 4 consecutive years, with -$33.1 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 258.33% to -$33.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$70.0 million through Dec 2025, down 16.94% year-over-year, with the annual reading at -$70.0 million for FY2025, 16.94% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$33.1 million at LENZ Therapeutics, down from -$9.0 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$9.0 million in Q3 2025, with the low at -$33.1 million in Q4 2025.
  • Average Free Cash Flow over 4 years is -$18.2 million, with a median of -$16.2 million recorded in 2025.
  • The sharpest move saw Free Cash Flow surged 47.77% in 2023, then crashed 258.33% in 2025.
  • Over 4 years, Free Cash Flow stood at -$23.4 million in 2022, then surged by 45.4% to -$12.8 million in 2023, then rose by 27.94% to -$9.2 million in 2024, then plummeted by 258.33% to -$33.1 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$33.1 million, -$9.0 million, and -$11.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.